Rwm. Van Deursen et al., Vibration perception threshold testing in patients with diabetic neuropathy: ceiling effects and reliability, DIABET MED, 18(6), 2001, pp. 469-475
Aims To test the reliability of a new vibrometer (Maxivibrometer) which was
constructed so that vibration perception threshold (VPT) could be determin
ed without the disadvantage of the off-scale measurements frequently experi
enced with the Biothesiometer.
Methods The two devices were compared and tested on a group of diabetic neu
ropathic subjects and a group of healthy, matched control subjects. VPT was
tested on the plantar surface of the feet.
Result The Maxivibrometer gave an actual measurement in all cases even if s
ubjects were severely neuropathic. The replication-to-replication and day-t
o-day intraclass correlation coefficients for the Maxivibrometer VPT were,
except in one case, above 0.94, indicating excellent reliability. The Bioth
esiometer VPT could also be measured with excellent reliability but only wi
thin a limited range of mild to moderate neuropathy, so it appears to be an
appropriate screening tool. The replication-to-replication intraclass corr
elation coefficient was 0.93.
Conclusions Because VPT could be measured over a wide range with the Maxivi
brometer, it was demonstrated that loss of sensation in diabetic neuropathy
can progress far beyond the maximum VPT value of the Biothesiometer. The w
ide measurement range and the excellent reliability make the Maxivibrometer
a valuable research tool to quantify loss of sensation, particularly in th
e presence of severe neuropathy and to record changes over time.